|
Delayed
Nasdaq
05:00:00 30/11/2016 HKT
|
5-day change | 1st Jan Change | ||
| 1.970 USD | +5.35% |
|
+4.23% | -80.50% |
| 10/04/15 | AbbVie : Venture capitalists ride biotech wave one drug at a time | RE |
| 15/01/15 | Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources | RE |
| 1 day | +5.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Zwinski
PSD | President | - | - |
Mike Gordon
SEC | Corporate Secretary | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Zwinski
BRD | Director/Board Member | - | - |
Mike Gordon
BRD | Director/Board Member | - | - |
Diego Ardigo
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.35% | +4.23% | - | - | 0 | ||
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | ||
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | ||
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | ||
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | ||
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | ||
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | ||
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | ||
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | ||
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | ||
| Average | +2.09% | +5.90% | +46.59% | +83.14% | 473.55B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.88% | +98.31% |
- Stock Market
- Stocks
- AEGR Stock
Select your edition
All financial news and data tailored to specific country editions
















